Buy Semax Nasal Spray

Direct Sourcing Guide: Acquiring Semax Nasal Spray for Preclinical Research

To buy Semax nasal spray or lyophilized Semax reagent for laboratory experimentation, qualified scientific entities can procure analytical-grade material directly from PX1 Research. Every batch is manufactured in USA-based, GMP-compliant facilities and thoroughly tested for purity exceeding 99% via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). PX1 Research ships directly from fulfillment hubs in California and Arizona with same-day dispatch for orders placed before cutoff times Monday through Friday.

When purchasing neuropeptide formulations for intranasal target delivery models, researchers must prioritize lot-specific documentation over unverified commercial claims. PX1 Research supplies a comprehensive Certificate of Analysis (COA) with every lot, establishing verified sequence identity, peptide content, heavy metal limits, and endotoxin levels. Laboratories conducting neurobiological assays or pharmacokinetic studies can review our full catalog of research peptides or explore institutional purchasing options via our wholesale account program.

Chemical Profile and Molecular Architecture of Semax

Semax is a synthetic heptapeptide analog derived from a specific fragment of adrenocorticotropic hormone, specifically ACTH(4-10). The primary amino acid sequence of Semax is Met-Glu-His-Phe-Pro-Gly-Pro (molecular formula: C37H51N9O10S; CAS number: 80714-61-5). The sequence integrates a Pro-Gly-Pro tripeptide structure at the C-terminus, a modification engineered to dramatically enhance metabolic stability against circulating proteases and peptidases.

In contrast to native ACTH fragments, which exhibit short half-lives in biological matrices, the C-terminal prolylglycylproline extension protects the peptide backbone from rapid enzymatic cleavage. This enzymatic resistance is critical in synthetic neuropeptide studies focusing on mucosal absorption and central nervous system bioavailability. In vitro degradation assays indicate that Semax maintains structural integrity far longer than unmodified adrenocorticotropic fragments, making it a reliable tool for investigating central signaling pathways.

Primary Mechanisms of Action in Preclinical Neurobiology

Preclinical studies suggest that Semax modulates central nervous system pathways through several distinct biochemical mechanisms. The primary focus of modern research centers on its capacity to upregulate neurotrophic factors, specifically brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), within the hippocampus and basal forebrain regions of rodent models.

In rodent assays, administration of Semax has been shown to rapidly increase BDNF mRNA expression and protein levels. BDNF binding to Tropomyosin receptor kinase B (TrkB) triggers intracellular signaling cascades, including the MAPK/ERK and PI3K/Akt pathways, which govern synaptic plasticity, neuronal survival, and dendritic spine remodeling. Additionally, in vitro data indicate that Semax alters transcriptional profiles related to neurotransmitter receptors, specifically modulating dopaminergic and serotonergic turnover without directly binding to primary classical monoamine receptors as a high-affinity agonist.

Research also highlights the role of Semax in vascular regulation and neuroprotection during oxidative stress models. In rodent focal ischemia assays, Semax administration influenced the expression of genes responsible for vascular endothelial growth factor (VEGF) and proinflammatory cytokines, suggesting a dual mechanism involving trophic support and inflammatory response attenuation.

Evaluating Intranasal Bioavailability and Delivery Pathways

The scientific interest in Semax nasal spray formats stems from the anatomical pathways connecting the nasal mucosa to the central nervous system. The olfactory and trigeminal nerve pathways provide a direct route that bypasses the blood-brain barrier (BBB), allowing hydrophilic peptide molecules to reach brain parenchyma without systemic degradation or extensive hepatic first-pass metabolism.

In preclinical animal models, intranasally administered radio-labeled Semax demonstrates rapid transport along olfactory nerve axons into the olfactory bulb, subsequently distributing into the striatum, cerebral cortex, and hippocampus. Researchers studying non-invasive central administration protocols frequently utilize customized intranasal delivery apparatuses for rodents to ensure precise volumetric dosing and reproducible mucosal contact times.

When preparing Semax peptide formulations for intranasal experiments, solution pH, osmolality, and vehicle composition must be controlled. Unbuffered aqueous solutions can cause mucosal irritation or variable absorption rates in animal subjects, while isotonic saline or buffered intranasal carriers maintain mucosal integrity and consistent peptide flux across epithelial tight junctions.

Comparative Analysis: Semax vs. Selank vs. N-Acetyl Semax Amidate

Within the domain of regulatory neuropeptide research, investigators frequently compare Semax to structurally or functionally related compounds to elucidate specific receptor responses or functional pathways. Understanding the structural differences among these analogs is essential when designing comparative preclinical trials.

While Semax acts primarily on BDNF transcription, neuroprotection, and vascular gene expression, its structural relative Selank is an analog of the immunomodulatory peptide tuftsin. Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) exhibits pronounced effects on enkephalin degradation enzymes and GABAergic signaling, making it a primary reference compound for anxiolytic and immune-modulatory animal studies. Conversely, structural variants like N-Acetyl Semax Amidate feature N-terminal acetylation and C-terminal amidation, modifications intended to further reduce susceptibility to exopeptidases and alter lipophilicity during blood-brain barrier transport assays. Selecting between these compounds depends on whether the laboratory protocol targets neurotrophic gene activation or GABA-mediated signaling pathways.

Preclinical Applications in Ischemia and Cognitive Models

A major area of published literature involves the evaluation of Semax in animal models of acute ischemic stroke and hypoxic brain injury. Transient middle cerebral artery occlusion (tMCAO) models in rodents have demonstrated that post-ischemic administration of Semax reduces cerebral infarct volume and mitigates neurological deficit scores compared to vehicle-treated controls.

The mechanisms underlying these neuroprotective outcomes include:

1. Suppression of proinflammatory cytokine mRNA expression (including IL-1b, IL-6, and TNF-a) in the ischemic penumbra. 2. Maintenance of microvascular integrity and reduction of local edema through vascular factor modulation. 3. Upregulation of anti-apoptotic signaling pathways, preventing delayed neuronal death in vulnerable hippocampal CA1 neurons.

In cognitive performance testing, such as the Morris water maze and passive avoidance tasks, rodent models exposed to neurotoxic challenges or age-related cognitive decline exhibited improved spatial learning and memory retention following treatment with Semax. These findings position the peptide as a critical standard in neuroprotective peptide research.

Quality Verification Criteria: Analytical Purity and Endotoxin Testing

Obtaining reliable, reproducible data in cell culture and animal studies requires research reagents that meet strict analytical parameters. Low-quality peptides containing deletion sequences, residual synthesis solvents, or endotoxins introduce confounding variables that compromise experimental validity.

At PX1 Research, every production lot of Semax undergoes stringent analytical verification:

• Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC): Confirms chemical purity levels exceeding 99%, ensuring the absence of truncated sequences or synthesis side products. • Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular weight and structural identity against theoretical peptide mass. • Bacterial Endotoxin Testing (LAL Assay): Guarantees endotoxin levels remain below 0.01 EU/mg, preventing unwanted inflammatory responses or microglial activation in sensitive cell and tissue assays.

All analytical procedures are performed by ISO 17025 accredited third-party laboratories, with verified documentation supplied alongside every order.

Laboratory Handling, Reconstitution, and Storage Protocols

To preserve the bioactivity of Semax for experimental use, proper storage and reconstitution procedures must be strictly maintained within the laboratory environment.

Upon receipt, lyophilized Semax powder should be stored at -20°C for short-term projects or -80°C for long-term storage, isolated from light and moisture. Lyophilized peptides remain stable under these desiccated conditions for up to 24 months.

For reconstitution, bring the vial to room temperature before adding liquid media to prevent condensation inside the container. Reconstitution should be performed using sterile bacteriostatic water, sterile 0.9% sodium chloride, or laboratory-grade phosphate-buffered saline (PBS) depending on the assay requirements. Gently swirl the solution to achieve complete dissolution; mechanical agitation or vortexing should be avoided as it can induce shear forces that aggregate peptide chains. Once reconstituted, liquid solutions should be aliquoted into single-use polypropylene tubes and stored at 4°C for short-term use (up to 14 days) or frozen at -20°C to prevent thermal degradation.

Institutional Procurement and Supply Chain Reliability with PX1 Research

Securing consistent, high-purity peptides for multi-phase scientific trials requires a dependable domestic supply chain. PX1 Research eliminates the risk of international customs delays, import seizures, and inconsistent overseas quality by manufacturing and stocking all compounds within the United States.

With dual dispatch facilities located in California and Arizona, PX1 Research provides rapid fulfillment across North America. Orders processed before 12:00 PM PST are dispatched the same day (Monday through Friday), utilizing temperature-controlled, secure packaging to maintain compound integrity during transit. Accredited university departments, private research organizations, and biotechnology firms can establish institutional accounts for batch reservation, custom synthesis, and bulk order fulfillment.